Alan M. Kelly, B.V.Sc, M.R.C.VS, Ph.D.
Professor, Dept of Pathobiology
Dean, School of Veterinary Medicine
3800 Spruce Street/6051
(215) 898-8841 FAX: (215) 573-8837
email: vetdean@vet.upenn.edu
Click here for selected publications since Dr. Kelly's arrival at Penn
RESEARCH INTERESTS
Development of neuromuscular specialization
RESEARCH TECHNIQUES
Monoclonal antibodies to myosin isozymes; oligonucleotide probes to myosin
in RNA's; SDS PAGE of myosin subunits
RESEARCH SUMMARY
Although the mdx mouse is a genetic homologue of Duchenne muscular dystrophy
(DMD) in man, murine limb muscle is reported to exhibit resistance to the
pathological consequences of dystrophin deficiency. This apparent species
difference has limited the utility of the mdx mouse in studies of the pathogenesis
and therapy of muscular dystrophy. We have shown that the respiratory muscles
of the mdx mouse undergo progressive degeneration and fibrosis. These dystrophic
changes are most advanced in the diaphragm where they are correlated with
profound alterations in the muscle's physiological properties. These changes
are evident by 3 months of age; by 18 months, the collagen density in the
mdx diaphragm is greater than seven times that of controls and the muscle
has shortened by 35%. By this stage, isometric strength per unit cross sectional
area has dropped by 80%. This is correlated with the elimination of type
IIx and a 50% increase in the proportion of slow fibers in the diaphragm.
The evolution of the dystrophic process in the respiratory muscles suggests
that the work of breathing is an important factor. Significantly, respiratory
failure is the leading cause of mortality associated with DMD. These findings
have relevance to the physiologic role of dystrophin, the membrane protein
that is deficient in dystrophic muscle. The function of dystrophin is not
known. In view of our findings, we have proposed that contraction-induced
injury leads to fiber disruption in dystrophic muscle. To test this postulate,
we have designed a simple functional assay involving the uptake of the fluorescent
dye, Procoin Orange (MW630) in stimulated muscle in vitro. Our results suggest
that dystrophin deficiency shifts the normal balance between injury and
repair in muscle towards the former by lowering the threshold for contraction
induced damage. Ultimate degeneration of dystrophin-deficient muscle would
therefore appear to result from the cumulative effects of heightened membrane
fragility with eventual overloading of muscle regenerative capacity.
KEY WORDS:
muscular dystrophy; therapy; pathogenesis
|